Dr. John K. Erban, MD

Expert Publications

• Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).
• Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk.
• Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.
• Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model.
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-2002. A 54-year-old man with hypercalcemia, renal dysfunction, and an enlarged liver.
• Phase II study of interferon gamma in malignant carcinoid tumors (E9292): a trial of the Eastern Cooperative Oncology Group.
• Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
• Letrozole or tamoxifen in early breast cancer.
• On the toxicity of chemotherapy for breast cancer--the need for vigilance.
• Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature.
• Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
• A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials.
• Secondary pulmonary alveolar proteinosis in hematologic malignancies.
• Promoting High-Quality Cancer Care and Equity Through Disciplinary Diversity in Team Composition.
• Rapid Change in Mental Status in a Patient with Hypereosinophilia.

Clinical Trials

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Media Releases

Get to know Hematologist-Oncologist Dr. John K. Erban, who serves patients in Boston, Massachusetts.

Hematologist-oncologist Dr. Erban is an internationally-renowned expert in breast cancer diagnosis and treatment. He serves as the Clinical Director of the Cancer Center at Tufts Medical Center in Boston, Massachusetts. He is also heavily involved in the Cancer Center’s Clinical Science Research Program as the Associate Director for Clinical Research.

The Cancer Center at Tufts Medical Center uses the most advanced technologies and techniques available to diagnose and treat all types of cancers. Preventative services include state-of-the-art genetic testing and risk-assessment counseling to help patients stay cancer-free throughout their lifetime. 

In the early days of his academic career, Dr. Erban obtained his medical degree from the Tufts University School of Medicine in 1981, where he is currently serving as a Professor. Furthering his education, he completed his training at the Hospital of the University of Pennsylvania and Tufts Medical Center.

A past president of the Massachusetts Society of Clinical Oncology, he previously served as Director of Clinical Programs & Co-Director of the Gillette Center at Massachusetts General Hospital and was an Associate Professor of Medicine at Harvard Medical School.

With over four decades of experience in his field, the doctor is board-certified in internal medicine, hematology, and medical oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

A leader in developing and conducting groundbreaking clinical trials in breast cancer, Dr. Erban’s research focuses on clinical investigations of locally advanced and metastatic breast cancer. He has published numerous articles, book chapters, and abstracts. He has also served on several editorial boards, including the Journal of Clinical Oncology, the American Journal of Clinical Oncology and Oncology, Index & Reviews. 

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma. 

A meticulous doctor and a dedicated volunteer, Dr. Erban has been named “Top Doctor” by Boston Magazine (2012, 2013, 2015, 2017, 2018, 2019, and 2020), “Top Cancer Doctors” by Newsweek (2015), as well as “Top Doctor” and in top 1% in the nation in his specialty by U.S. News & World Report (2012). 

Recommended Articles

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• The Promising Future of Gene Therapy and Lymphoma

  Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...

• Nurse Donates Breast Milk for Lymphoma Patient's Baby

  Ashley Chestnut, a mother of two children from La Vista, Nebraska, was breastfeeding her 5-month-year-old son Easton when she began to experience a sharp and sudden pain in her shoulder and chest. “All of a sudden a sharp pain in my shoulder and chest, it was like hitting a freight train. It was...

• Overcoming Lymphoma: A South Philly Student's Story

  In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...

• Teen Treated for Lymphoma to Play College Baseball

  Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...

• Genetic Advancements in Lymphoma Treatment

  Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...